Cenkos Securities Share Discussion Threads

[ggbarabajagal] 11/1/2017 09:34

82-5 tempted to add more , cant gave too much of a good thing

[ggbarabajagal] 11/1/2017 08:57

quiet board

price rocking on

[ggbarabajagal] 09/1/2017 10:55

GOLSMAN AND ALL THE MERCHANT BANKS ON NEW HIGHS

UP 40PC SINCE TRUMP


THIS SILLY PRICE


BUT HIGH VOLUME COMING IN

[ggbarabajagal] 09/1/2017 10:53

Got in here

[wooluf] 09/1/2017 08:06

move up early doors

[topvest] 08/1/2017 14:28

Here you go.
hxxp://www.17yearstockmarketcycle.com

Its certainly an interesting read. Probably not as precise a science as the author makes out, but its well founded that the stock market has operated in 18 year cycles and we are towards the end of a long sideways bear market when the Dow and FTSE corrects, as they surely will at some point fairly soon.

Cenkos also looking interesting as a top-up at some point, although will await the results first.

[tenapen] 08/1/2017 12:50

topvest 5 Jan '17 - 20:09 - 2112 of 2114
..... The 17.6 year stock market cycle if you are interested.

--------

Hi topvest, im always 'interested' in what you have to post. Were you going to post a link to explain the '17.6 year stock market cycle' ?

Thanks.

[luckymouse] 06/1/2017 16:22

Took them long enough to notice it lol

[zho] 06/1/2017 15:50

340,000 bought in last 40 minutes. A tip, or something leaking?

[topvest] 05/1/2017 20:09

AIM will bounce back in my view. We are still in an 18-year bear market in my view (not that it currently feels like it) that will finish in 2017/2018 with another down-turn which will end up with the FTSE-100 falling back a thousand points at least and being below where it was in 2000. We will then be in to an 18 year secular bull market and things will start looking up. Its a long time since the crazy days of 1999/2000! Lets face it hardly anyone buys shares. The 17.6 year stock market cycle if you are interested.

[quepassa] 05/1/2017 11:07

Today's FT. Page 17. Small column headed "AIM- Fall in listings"

Interesting to read. Some snippets:-


There are currently 36 Nomads. In 2013 there were more than 50 Nomads.

The number of AIM-listed companies has fallen faster. Now below 1,000 for first time since 2004. This is now down 40% to 993 AIM companies since the peak in 2007 of 1,694 companies listed on AIM.

Last year there were only 38 full IPO's on AIM.

in 2007 AIM Companies raised more than £16.2billion. Last year 2016, just £4.9bn.

The implementation of MIFID II is expected to push down commissions for brokers, reducing another revenue source.



Some stark facts about AIM and a sobering article perhaps about prospects for AIM related business.

It appears to me in my opinion only that the strong may survive but the weak and walking-wounded may further suffer or be forced to withdraw entirely from a significantly reduced and much tougher arena.


ALL IMO. DYOR.
QP

[quepassa] 21/12/2016 06:02

It is not going to bounce back in my opinion until the findings of the SFO investigation into Quindell are published.

From circa 170p to the current 70p in a year is telling you something.


ALL IMO. DYOR.
QP

[speedsgh] 20/12/2016 22:32

CWA - Had a look at this earlier & not sure there is anything of any consequence in it for Cenkos..."Jefferies International Limited ("Jefferies") and Greenhill & Co. International LLP ("Greenhill") acting as Financial Advisers to the Company, are both authorised and regulated in the United Kingdom by the Financial Conduct Authority, and are each acting for the Company..."

[topvest] 20/12/2016 19:14

Yes, agreed. Just sneaked that one into 2016. Still a poor year for Cenkos, but hopefully they will bounce back and do some good deals in 2017.

[cwa1] 20/12/2016 17:21

Not sure just how lucrative this type of work is-but it must put a couple of crusts on the table for the NOMAD:-

[keith95] 16/12/2016 13:33

.... another update on Cenkos web site with more IPO/placings.

[speedsgh] 12/12/2016 10:05

Cenkos are acting on £10m placing for Marlowe (MRL). Cenkos are Nomad/broker...

Placing to raise approximately £10 million -

The Placing will raise approximately £10 million before expenses through the issue of 3,450,000 new ordinary shares of 50 pence each (the "Placing Shares") at 290 pence per share (the "Issue Price") to certain existing and new investors. The Placing was oversubscribed and the Issue Price is equal to the mid-market closing price per share of 290 pence on Friday 9 December 2016.

The Company will raise approximately £10 million gross proceeds (approximately £9.7 million net of expenses) through the Placing of the Placing Shares at the Issue Price through Cenkos Securities plc ("Cenkos").

[luckymouse] 10/12/2016 12:55

Reasonably sure it will bounce off one of those levels - they are pretty clear so everyone will see them - some good news in the buyzzone always helps provide the fundamental catalyst too

free stock charts from uk.advfn.com

[topvest] 10/12/2016 12:11

Yes, my strategy here is to await the final results now and potentially double up at that stage. Think Cenkos will bounce back, but obviously 2016 has been a poor year.

[garycook] 10/12/2016 04:06

Can only get better from here, and next year.

[speedsgh] 07/12/2016 13:30

Yes, imran. Numis are in the league that Cenkos would like to be in but they're a long way off achieving it yet imo.

[imranawan] 07/12/2016 13:17

I was thinking the same speedsgh. I thought NUM performance was very impressive relative to Cenkos.

I suppose it shows what could happen if Cenkos can improve their performance.

[speedsgh] 07/12/2016 11:33

Fairly impressive results from Numis today in view of the backdrop. Rather puts little old Cenkos to shame...

Preliminary Results for the year ended 30 Sep 2016 -

[speedsgh] 06/12/2016 17:57

Further to posts #2087 & #2094, confirmation today that Cenkos have managed to raise £20m on behalf of Creo Medical Group as part of their AIM IPO.

Creo Medical Proposed Admission to Trading on AIM -

The Company has conditionally raised £20 million through a placing with institutional and other investors at a placing price of 76 pence per ordinary share (the "Placing Price"). Creo's market capitalisation on Admission, based on the Placing Price, is expected to be approximately £61.3 million.

Cenkos Securities plc acted as sole Nominated Adviser and Broker to Creo for the IPO.